{"result": {"id": "chatcmpl-557", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "**CLINICAL TRIALS** are research studies designed to test new treatments and methods of treatment.  They focus on evaluating the effectiveness of new treatments for **low-flow vascular malformations**. Additionally, clinical trials are investigating the effectiveness of antivascular agents combined with chemotherapy, immune checkpoint inhibitors, and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for treating patients with advanced nonsmall cell lung cancer. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743288516, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 83, "prompt_tokens": 225, "total_tokens": 308, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"CLINICAL TRIALS\"\nDescription List: [\"\", \"Clinical trials are research studies designed to test new treatments and methods of treatment.  Specifically, they focus on evaluating the effectiveness of new treatments for low-flow vascular malformations.  Another set of clinical trials is investigating the effectiveness of antivascular agents combined with chemotherapy, immune checkpoint inhibitors, and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for treating patients with advanced nonsmall cell lung cancer. \\n\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_34794f6e6d2a893557ee36b5118d645b1d8ca27c592f46e0f6beca8984714485_v2"}